![Michael Bonney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bonney
Chairman at AUTOLUS THERAPEUTICS PLC
Net worth: 9 M $ as of 29/11/2025
Profile
Michael W. Bonney is a businessperson who has been at the helm of 7 different companies. He occupies the position of Chairman at Alnylam Pharmaceuticals, Inc., Chairman for Kaleido Biosciences, Inc. and Chairman for Magenta Therapeutics, Inc. He is also on the board of Bristol Myers Squibb Co., Life Sciences Cares and X-Biotix Therapeutics, Inc. and Chairman of Bates College. In the past he held the position of Chairman of Rare LLC (Virginia), Director-National Business at Zeneca Pharmaceuticals, Partner at Third Rock Ventures LLC, Vice President-Sales & Marketing at Biogen, Inc., Director at Cubist Pharmaceuticals LLC, Chairman of Gulf of Maine Research Institute and Director at Biotechnology Innovation Organization. Mr. Bonney received an undergraduate degree from Bates College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/08/2025 | 20,804 ( 0.02% ) | 9 M $ | 29/11/2025 | |
| 28/02/2025 | 0 ( -.--% ) | - $ | 29/11/2025 |
Latest news about Michael Bonney
Michael Bonney active positions
| Companies | Position | Start |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Chairman | 31/03/2024 |
X-Biotix Therapeutics, Inc.
 X-Biotix Therapeutics, Inc. Engages in research and development in biotechnology | Director/Board Member | 20/04/2020 |
Gulf of Maine Research Institute
 Gulf of Maine Research Institute Miscellaneous Commercial ServicesCommercial Services Operates research institute that provides collaborative solutions to global ocean challenges | Director/Board Member | - |
Dunad Therapeutics Ltd.
 Dunad Therapeutics Ltd. Develops oral protein degradation therapies | Chairman | 08/01/2023 |
Life Sciences Cares
 Life Sciences Cares Operates organization to eradicate poverty | Director/Board Member | - |
Former positions of Michael Bonney
| Companies | Position | End |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chairman | 04/01/2023 |
| KALEIDO BIOSCIENCES, INC. | Chief Executive Officer | 20/08/2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Director/Board Member | 02/08/2021 |
| MAGENTA THERAPEUTICS | Chairman | 02/08/2021 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Michael Bonney
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 32 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Manufactures and markets biopharmaceuticals products | |
Celgene Corp.
 Celgene Corp. Develops cancer and immunology drugs | |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
abrdn Healthcare Investors
 abrdn Healthcare Investors Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
abrdn Life Sciences Investors
 abrdn Life Sciences Investors Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
abrdn Healthcare Opportunities Fund
 abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
abrdn World Healthcare Fund
 abrdn World Healthcare Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Tekla Capital Management LLC
 Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Finance |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Bates College
 Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for early stage capital requirements. The firm also acts as a lead investor. | Finance |
Gulf of Maine Research Institute
Gulf of Maine Research Institute Miscellaneous Commercial ServicesCommercial Services Operates research institute that provides collaborative solutions to global ocean challenges | Commercial Services |
Pharmaceutical Manufacturers Association of America | |
Zeneca Pharmaceuticals
 Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Engages in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders | |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Operates as a therapeutics company focusing on discovering and developing novel gene control therapies | |
Rare (Virginia)
 Rare (Virginia) Operates as a nonprofit organization that engages in driving social change for people and nature | |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Develops new therapies derived from natural products | |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Develops and manufactures novel medicines | |
Life Sciences Cares
Life Sciences Cares Operates organization to eradicate poverty | |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. Engages in research and development in biotechnology | |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Engages in the development and commercialization of gene therapies | |
Dunad Therapeutics Ltd.
Dunad Therapeutics Ltd. Develops oral protein degradation therapies |
- Stock Market
- Insiders
- Michael Bonney
